CLINICAL_TRIALS
trial_result
· 2014-12-03
Clinical Trial Update: The Study Of Fluconazole For Vulvovaginal Candidiasis [Phase 3]
Summary
Phase 3 clinical trial update for fluconazole in vulvovaginal candidiasis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Vulvovaginal Candidiasis | Phase 3 | Status: COMPLETED | Results posted: 2014-12-03